Mumbai, May 22, 2022: Karkinos Healthcare, a technology-driven, oncology focused managed health care platform, today announced that the prestigious, nonprofit American academic medical center Mayo Clinic has invested a minority stake in the company, subject to certain conditions precedent.Mayo Clinic will also nominate a member on the Board of Directors of Karkinos Healthcare as part of this agreement. The company, which is pioneering the Distributed Cancer Care Network model for cancer care, has Ratan Tata, Venu Srinivasan, Kris Gopalakrishnan, Ronnie Screwvala, Vijay Shekar Sharma, and Bhavish Agarwal amongst its set of investors. The Tata Group is investing Rs. 110 crore in Karkinos, while Rakuten Medical, the global clinical stage biotechnology company, and Reliance Digital Health, a subsidiary of Reliance Industries, hold minority stakes. Venture Capital fund Endiya Partners also has a stake in the company.Karkinos is pioneering the Distributed Cancer Care Network model in India addressing clinical needs of cancer patients.
Built on a robust technology platform, the company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing care closer to patients. Karkinos already offers its services in Kothamangalam, Chottanikkara, Thodupuzha, Munnar locations across Ernakulum and Idukki Districts, in Kerala and is planning to ramp up its operations across India. The company is also setting up a Cancer Centre in Jawaharlal Nehru Institute of Medical Sciences (JNIMS) premises at Imphal, in partnership with Government of Manipur.
Ad Statistics
Times Displayed: 22487
Times Visited: 455 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About Karkinos Healthcare
Karkinos Healthcare is a technology driven oncology focussed managed health care platform for early detection and diagnosis of common cancers. The company espouses the use of a distributed cancer care network working with multiple healthcare institutions and professionals in the ecosystem with a view to get cancer care closer to the persons’ home by decoupling the delivery from the knowledge systems of care.
